Resources & Evidence Contact us

Clinically shown, human milk–based nutrition

More than 100,000 premature infants throughout the world have experienced proven clinical benefits from Prolacta’s 100% human milk–based nutritional products.1

Improve health outcomes2,3,4,5,6,7 including:

  • Bronchopulmonary dysplasia (BPD)8,9,5,6
  • Late-onset sepsis8,5,7
  • Retinopathy of prematurity (ROP)8,5,6
  • Necrotizing enterocolitis (NEC)6,2,5

When used as part of an exclusive human milk diet (EHMD) as compared to cow milk–based products, Prolacta’s products have been shown in clinical studies to:

  • Achieve adequate growth9,10,11
  • Reduce feeding intolerance6
  • Lower incidence of mortality and morbidity3,4,5
  • Shorten neonatal intensive care unit (NICU) stays6
  • Reduce hospital costs6,12

Premature infant nutrition


Supplementing mother’s own milk (MOM) with the first commercially available human milk–based fortifier made from 100% human donor milk instead of cow milk

Caloric fortifier

When premature infants need additional calories to support their growth, this human milk–based caloric fortifier delivers


This ready-to-feed, human milk–based product offers NICUs an alternative to cow milk-based formula when MOM is not available

Human donor milk

When an adequate supply of MOM is not available, donor milk is rapidly becoming the standard of care for feeding premature infants

Adequately nourishing infants with mother’s own milk (MOM) fortified with human milk–based products

Since 2012, the American Academy of Pediatrics (AAP) has recommended human milk for preterm infants, whether MOM or pasteurized donor human milk if MOM is unavailable. For those infants born weighing less than 1500 g, the AAP recommends fortifying MOM or donor human milk with protein and minerals to ensure optimal nutrient intake.13 Our products help hospitals meet the nutritional needs of their medically fragile patients in the NICU.

Made with lab-tested donor milk in U.S. FDA-regulated manufacturing facilities

Hospitals choose Prolacta’s 100% human milk–based nutritional products for the assurance that they are receiving safe, standardized donor milk formulations processed in a pharmaceutical-grade facility under the strictest quality and safety guidelines to protect the health and well-being of their most fragile patients1.

A cost-effective solution

When used as part of an EHMD, our human milk–based nutritional products are clinically shown to increase survival and reduce the overall cost of care compared to cow milk–based fortifier or preterm formula in extremely premature infants. 4, 5

Tell us how we can help

Clinician-to-clinician guidance

Coding, billing and reimbursement questions

Finding my sales representative

Support with an order